About Retia medical
Retia Medical: Revolutionizing Hemodynamic Management with Argos Cardiac Output Monitor
Retia Medical is a leading medical device company that specializes in developing innovative solutions for hemodynamic management. The company's flagship product, the Argos Cardiac Output Monitor, is a highly accurate and reliable device that provides superior CO monitoring performance, quality, simplicity, and compatibility.
Hemodynamic management is an essential aspect of critical care medicine that involves monitoring and optimizing the cardiovascular system's function. It plays a crucial role in managing patients with various conditions such as sepsis, heart failure, shock, and trauma. Accurate measurement of cardiac output (CO) is one of the key parameters in hemodynamic monitoring as it reflects the heart's ability to pump blood to meet the body's metabolic demands.
The Argos Cardiac Output Monitor from Retia Medical offers several advantages over traditional CO monitoring methods such as thermodilution or Doppler ultrasound. It uses a proprietary algorithm based on pulse contour analysis (PCA) to calculate CO continuously and non-invasively from arterial pressure waveforms obtained from standard arterial lines or catheters. This approach eliminates the need for costly disposable sensors or probes and reduces the risk of infection or complications associated with invasive procedures.
Moreover, PCA-based CO measurement has been shown to be more accurate than other non-invasive methods such as impedance cardiography or transthoracic echocardiography. The Argos monitor also provides additional hemodynamic parameters such as stroke volume (SV), systemic vascular resistance (SVR), cardiac index (CI), and dynamic indices like pulse pressure variation (PPV) or stroke volume variation (SVV). These parameters can help clinicians assess fluid responsiveness, guide fluid therapy titration, detect changes in vascular tone or contractility, monitor response to interventions like vasopressors or inotropes.
Retia Medical has designed its Argos monitor with user-friendliness in mind. The device has a simple and intuitive interface that allows clinicians to set up and operate it quickly. It also has a compact and portable design that makes it easy to transport between different care settings such as ICU, OR, or ED. The monitor can be connected to various patient monitors or electronic medical records (EMR) systems via standard interfaces like HL7 or DICOM.
The Argos Cardiac Output Monitor is compatible with most adult patients (>40 kg) regardless of their cardiac rhythm, ventilation mode, or vasoactive support. It has been validated in several clinical studies involving critically ill patients in various settings such as sepsis, ARDS, cardiac surgery, liver transplantation, or trauma. These studies have demonstrated the device's accuracy and reliability compared to reference methods like thermodilution or transpulmonary thermodilution.
Retia Medical is committed to providing excellent customer service and support for its customers worldwide. The company offers comprehensive training programs for clinicians and technicians who use the Argos monitor. It also provides technical assistance through its dedicated hotline or online portal.
In conclusion, Retia Medical's Argos Cardiac Output Monitor represents a significant advancement in hemodynamic monitoring technology. Its unique combination of accuracy, simplicity, compatibility makes it an attractive option for critical care providers who seek reliable CO measurement without invasive procedures' drawbacks. With its growing body of evidence supporting its clinical utility and user-friendly features' adoption rate is expected to increase rapidly in the coming years.